Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Engelhardt

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cell Communication and Signaling : CCS|November 23, 2023
P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophagesJudith Bockstiegel, Jonas Engelhardt, Günther Weindl
Molecular Medicine (Cambridge, Mass.)|February 21, 2025
The vasoconstrictor adenosine 5'-tetraphosphate is a danger signal that induces IL-1βJudith Bockstiegel, Jonas Engelhardt, Mirjam Schuchardt, et al.
Biochemical Pharmacology|July 22, 2023
Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1β releaseJudith Bockstiegel, Silas L Wurnig, Jonas Engelhardt, et al.
Plos One|August 5, 2021
Fusarium graminearum DICER-like-dependent sRNAs are required for the suppression of host immune genes and full virulenceBernhard Timo Werner, Aline Koch, Ena Šečić, et al.
ACS Pharmacology & Translational Science|January 16, 2025
Lipopolysaccharide-Neutralizing Peptide Modulates P2X7 Receptor-Mediated Interleukin-1β ReleaseJonas Engelhardt, Anna Klawonn, Ann-Kathrin Dobbelstein, et al.
Chemical Communications (Cambridge, England)|January 23, 2025
Degrading the key component of the inflammasome: development of an NLRP3 PROTACTim Keuler, Dominic Ferber, Jonas Engelhardt, et al.
Bioorganic Chemistry|January 7, 2024
Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory propertiesFabian B Kraft, Jana Enns, Irina Honin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cell Communication and Signaling : CCS|November 23, 2023
P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophagesJudith Bockstiegel, Jonas Engelhardt, Günther Weindl
Molecular Medicine (Cambridge, Mass.)|February 21, 2025
The vasoconstrictor adenosine 5'-tetraphosphate is a danger signal that induces IL-1βJudith Bockstiegel, Jonas Engelhardt, Mirjam Schuchardt, et al.
Biochemical Pharmacology|July 22, 2023
Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1β releaseJudith Bockstiegel, Silas L Wurnig, Jonas Engelhardt, et al.
Plos One|August 5, 2021
Fusarium graminearum DICER-like-dependent sRNAs are required for the suppression of host immune genes and full virulenceBernhard Timo Werner, Aline Koch, Ena Šečić, et al.
ACS Pharmacology & Translational Science|January 16, 2025
Lipopolysaccharide-Neutralizing Peptide Modulates P2X7 Receptor-Mediated Interleukin-1β ReleaseJonas Engelhardt, Anna Klawonn, Ann-Kathrin Dobbelstein, et al.
Chemical Communications (Cambridge, England)|January 23, 2025
Degrading the key component of the inflammasome: development of an NLRP3 PROTACTim Keuler, Dominic Ferber, Jonas Engelhardt, et al.
Bioorganic Chemistry|January 7, 2024
Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory propertiesFabian B Kraft, Jana Enns, Irina Honin, et al.
Pageof 1